Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Madrigal Pharmaceuticals (MDGL) over the last 9 years, with Q3 2025 value amounting to $779923.0.

  • Madrigal Pharmaceuticals' Treasury Shares rose 5509.53% to $779923.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $779923.0, marking a year-over-year increase of 5509.53%. This contributed to the annual value of $499559.0 for FY2024, which is 3282.01% up from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported Treasury Shares of $779923.0 as of Q3 2025, which was up 5509.53% from $757263.0 recorded in Q2 2025.
  • Madrigal Pharmaceuticals' 5-year Treasury Shares high stood at $779923.0 for Q3 2025, and its period low was $199125.0 during Q1 2023.
  • In the last 3 years, Madrigal Pharmaceuticals' Treasury Shares had a median value of $502867.0 in 2024 and averaged $489412.2.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 16650.14% in 2024, then skyrocketed by 3096.53% in 2025.
  • Madrigal Pharmaceuticals' Treasury Shares (Quarter) stood at $376117.0 in 2023, then skyrocketed by 32.82% to $499559.0 in 2024, then surged by 56.12% to $779923.0 in 2025.
  • Its Treasury Shares was $779923.0 in Q3 2025, compared to $757263.0 in Q2 2025 and $694995.0 in Q1 2025.